APOBEC3A and cancer: Thus, high expression levels and deaminase activity seemingly implicate APOBEC3B as the major mutator in all of the cancer cell lines analysed here, whereas analyses of extended sequence contexts and RNA-editing assays suggest a potential role for APOBEC3A.